Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2025-12-30 @ 11:50 PM
Study NCT ID:
NCT00436904
Status:
COMPLETED
Last Update Posted:
2011-12-01
First Post:
2007-02-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Alemtuzumab and Rituximab in Treating Patients With High-Risk, Early-Stage Chronic Lymphocytic Leukemia
Sponsor:
Mayo Clinic
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CDR0000529809
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |